These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 31885896)
21. The influence of central corneal thickness on response to topical prostaglandin analogue therapy. Birt CM; Buys YM; Kiss A; Trope GE; Can J Ophthalmol; 2012 Feb; 47(1):51-4. PubMed ID: 22333852 [TBL] [Abstract][Full Text] [Related]
22. Validity of the Monocular Trial of Intraocular Pressure-Lowering at Different Time Points in Patients Starting Topical Glaucoma Medication. King AJ; Rotchford AP JAMA Ophthalmol; 2016 Jul; 134(7):742-7. PubMed ID: 27148831 [TBL] [Abstract][Full Text] [Related]
23. Latanoprost : an update of its use in glaucoma and ocular hypertension. Perry CM; McGavin JK; Culy CR; Ibbotson T Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627 [TBL] [Abstract][Full Text] [Related]
24. Periorbital changes associated with prostaglandin analogs in Korean patients. Kim HW; Choi YJ; Lee KW; Lee MJ BMC Ophthalmol; 2017 Jul; 17(1):126. PubMed ID: 28716077 [TBL] [Abstract][Full Text] [Related]
25. Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension. Tamçelik N; Izgi B; Temel A; Yildirim N; Okka M; Özcan A; Yüksel N; Elgin U; Altan Ç; Ozer B Clin Ophthalmol; 2017; 11():723-731. PubMed ID: 28458511 [TBL] [Abstract][Full Text] [Related]
26. Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database. Denis P; Lafuma A; Berdeaux G Clin Ophthalmol; 2008 Jun; 2(2):321-9. PubMed ID: 19668723 [TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure. Quaranta L; Riva I; Katsanos A; Floriani I; Centofanti M; Konstas AG Clin Ophthalmol; 2015; 9():633-43. PubMed ID: 25914522 [TBL] [Abstract][Full Text] [Related]
29. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension. Easthope SE; Perry CM Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension. Katz LJ; Simmons ST; Craven ER Curr Med Res Opin; 2007 Dec; 23(12):2971-83. PubMed ID: 17949534 [TBL] [Abstract][Full Text] [Related]
31. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials. Li N; Chen XM; Zhou Y; Wei ML; Yao X Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898 [TBL] [Abstract][Full Text] [Related]
32. Travoprost--a new prostaglandin analogue for the treatment of glaucoma. Whitson JT Expert Opin Pharmacother; 2002 Jul; 3(7):965-77. PubMed ID: 12083996 [TBL] [Abstract][Full Text] [Related]
33. Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients. Aihara M; Adachi M; Matsuo H; Togano T; Fukuchi T; Sasaki N; Acta Ophthalmol; 2017 Dec; 95(8):e720-e726. PubMed ID: 28371482 [TBL] [Abstract][Full Text] [Related]
34. Intraocular pressure lowering effect of dorzolamide/timolol fixed combination in patients with glaucoma who were unresponsive to prostaglandin analogs/prostamides. Martínez A; Sánchez M Curr Med Res Opin; 2007 Mar; 23(3):595-9. PubMed ID: 17355740 [TBL] [Abstract][Full Text] [Related]
35. IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma. Hommer A; Mohammed Ramez O; Burchert M; Kimmich F Curr Med Res Opin; 2010 Aug; 26(8):1905-13. PubMed ID: 20553122 [TBL] [Abstract][Full Text] [Related]
36. Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma. Faridi UA; Saleh TA; Ewings P; Venkateswaran M; Cadman DH; Samarasinghe RA; Vodden J; Claridge KG Clin Exp Ophthalmol; 2010 Oct; 38(7):678-82. PubMed ID: 20456437 [TBL] [Abstract][Full Text] [Related]
37. The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucoma. Meda R; Wang Q; Paoloni D; Harasymowycz P; Brunette I Br J Ophthalmol; 2017 Feb; 101(2):120-125. PubMed ID: 27162226 [TBL] [Abstract][Full Text] [Related]
38. Omidenepag isopropyl for the treatment of glaucoma and ocular hypertension. Ferro Desideri L; Cutolo CA; Barra F; Ferrero S; Traverso CE Drugs Today (Barc); 2019 Jun; 55(6):377-384. PubMed ID: 31250842 [TBL] [Abstract][Full Text] [Related]